Key statistics
On Tuesday, Apollomics Inc (APLM:NAQ) closed at 0.142, 34.85% above the 52 week low of 0.1053 set on Sep 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.149 |
---|---|
High | 0.149 |
Low | 0.13 |
Bid | 0.121 |
Offer | 0.150 |
Previous close | 0.1472 |
Average volume | 1.23m |
---|---|
Shares outstanding | 109.97m |
Free float | 57.79m |
P/E (TTM) | -- |
Market cap | 15.62m USD |
EPS (TTM) | -0.568 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Announcements
- Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024
- Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress
- Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial
- Apollomics to Present at the Canaccord Genuity 44th Annual Growth Conference
- Apollomics Granted 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement
- Apollomics Announces Updated Strategic Focus and Leadership Team Changes
- Apollomics Announces Vebreltinib Data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Apollomics Announces Presentation at the 2024 BIO International Convention
- Apollomics Announces Private Placement Financing and Addition to Board of Directors
More ▼